Press "Enter" to skip to content

AstraZeneca halts Oxford coronavirus vaccine trial after participant develops unexpected illness

In a news that comes as a temporary setback for world’s effort to get a coronavirus vaccine, pharmaceutical company AstraZeneca on Tuesday announced that it had “voluntarily paused” a randomised clinical trial of its COVID-19 vaccine after a participant developed an unexpected illness. AstraZeneca has got the license for manufacturing the vaccine being developed at the University of Oxford. The Oxford vaccine is a frontrunner in the global race. 

Leave your comments

%d bloggers like this: